Concepedia

Publication | Open Access

HDAC5, a potential therapeutic target and prognostic biomarker, promotes proliferation, invasion and migration in human breast cancer

DOIFull Paper Access

73

Citations

21

References

2016

Year

Anqi Li, Zebing Liu, Ming Li, Shuling Zhou, Yan Xu, Yaoxing Xiao, Wentao Yang
Oncotarget

Abstract

Our findings indicate that HDAC5 is a promising prognostic marker and drug target for BC and that the combination of LMK-235 and bortezomib presents a novel therapeutic strategy for BC.

References

YearCitations

Page 1